Cargando…

Variation in antibiotic treatment for diabetic patients with serious foot infections: A retrospective observational study

BACKGROUND: Diabetic foot infections are common, serious, and diverse. There is uncertainty about optimal antibiotic treatment, and probably substantial variation in practice. Our aim was to document whether this is the case: A finding that would raise questions about the comparative cost-effectiven...

Descripción completa

Detalles Bibliográficos
Autores principales: Fincke, Benjamin G, Miller, Donald R, Christiansen, Cindy L, Turpin, Robin S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914722/
https://www.ncbi.nlm.nih.gov/pubmed/20604922
http://dx.doi.org/10.1186/1472-6963-10-193
_version_ 1782184784969072640
author Fincke, Benjamin G
Miller, Donald R
Christiansen, Cindy L
Turpin, Robin S
author_facet Fincke, Benjamin G
Miller, Donald R
Christiansen, Cindy L
Turpin, Robin S
author_sort Fincke, Benjamin G
collection PubMed
description BACKGROUND: Diabetic foot infections are common, serious, and diverse. There is uncertainty about optimal antibiotic treatment, and probably substantial variation in practice. Our aim was to document whether this is the case: A finding that would raise questions about the comparative cost-effectiveness of different regimens and also open the possibility of examining costs and outcomes to determine which should be preferred. METHODS: We used the Veterans Health Administration (VA) Diabetes Epidemiology Cohorts (DEpiC) database to conduct a retrospective observational study of hospitalized patients with diabetic foot infections. DEpiC contains computerized VA and Medicare patient-level data for VA patients with diabetes since 1998, including demographics, ICD-9-CM diagnostic codes, antibiotics prescribed, and VA facility. We identified all patients with ICD-9-CM codes for cellulitis/abscess of the foot and then sub-grouped them according to whether they had cellulitis/abscess plus codes for gangrene, osteomyelitis, skin ulcer, or none of these. For each facility, we determined: 1) The proportion of patients treated with an antibiotic and the initial route of administration; 2) The first antibiotic regimen prescribed for each patient, defined as treatment with the same antibiotic, or combination of antibiotics, for at least 5 continuous days; and 3) The antibacterial spectrum of the first regimen. RESULTS: We identified 3,792 patients with cellulitis/abscess of the foot either alone (16.4%), or with ulcer (32.6%), osteomyelitis (19.0%) or gangrene (32.0%). Antibiotics were prescribed for 98.9%. At least 5 continuous days of treatment with an unchanged regimen of one or more antibiotics was prescribed for 59.3%. The means and (ranges) across facilities of the three most common regimens were: 16.4%, (22.8%); 15.7%, (36.1%); and 10.8%, (50.5%). The range of variation across facilities proved substantially greater than that across the different categories of foot infection. We found similar variation in the spectrum of the antibiotic regimen. CONCLUSIONS: The large variations in regimen appear to reflect differences in facility practice styles rather than case mix. It is unlikely that all regimens are equally cost-effective. Our methods make possible evaluation of many regimens across many facilities, and can be applied in further studies to determine which antibiotic regimens should be preferred.
format Text
id pubmed-2914722
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29147222010-08-04 Variation in antibiotic treatment for diabetic patients with serious foot infections: A retrospective observational study Fincke, Benjamin G Miller, Donald R Christiansen, Cindy L Turpin, Robin S BMC Health Serv Res Research Article BACKGROUND: Diabetic foot infections are common, serious, and diverse. There is uncertainty about optimal antibiotic treatment, and probably substantial variation in practice. Our aim was to document whether this is the case: A finding that would raise questions about the comparative cost-effectiveness of different regimens and also open the possibility of examining costs and outcomes to determine which should be preferred. METHODS: We used the Veterans Health Administration (VA) Diabetes Epidemiology Cohorts (DEpiC) database to conduct a retrospective observational study of hospitalized patients with diabetic foot infections. DEpiC contains computerized VA and Medicare patient-level data for VA patients with diabetes since 1998, including demographics, ICD-9-CM diagnostic codes, antibiotics prescribed, and VA facility. We identified all patients with ICD-9-CM codes for cellulitis/abscess of the foot and then sub-grouped them according to whether they had cellulitis/abscess plus codes for gangrene, osteomyelitis, skin ulcer, or none of these. For each facility, we determined: 1) The proportion of patients treated with an antibiotic and the initial route of administration; 2) The first antibiotic regimen prescribed for each patient, defined as treatment with the same antibiotic, or combination of antibiotics, for at least 5 continuous days; and 3) The antibacterial spectrum of the first regimen. RESULTS: We identified 3,792 patients with cellulitis/abscess of the foot either alone (16.4%), or with ulcer (32.6%), osteomyelitis (19.0%) or gangrene (32.0%). Antibiotics were prescribed for 98.9%. At least 5 continuous days of treatment with an unchanged regimen of one or more antibiotics was prescribed for 59.3%. The means and (ranges) across facilities of the three most common regimens were: 16.4%, (22.8%); 15.7%, (36.1%); and 10.8%, (50.5%). The range of variation across facilities proved substantially greater than that across the different categories of foot infection. We found similar variation in the spectrum of the antibiotic regimen. CONCLUSIONS: The large variations in regimen appear to reflect differences in facility practice styles rather than case mix. It is unlikely that all regimens are equally cost-effective. Our methods make possible evaluation of many regimens across many facilities, and can be applied in further studies to determine which antibiotic regimens should be preferred. BioMed Central 2010-07-06 /pmc/articles/PMC2914722/ /pubmed/20604922 http://dx.doi.org/10.1186/1472-6963-10-193 Text en Copyright ©2010 Fincke et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Fincke, Benjamin G
Miller, Donald R
Christiansen, Cindy L
Turpin, Robin S
Variation in antibiotic treatment for diabetic patients with serious foot infections: A retrospective observational study
title Variation in antibiotic treatment for diabetic patients with serious foot infections: A retrospective observational study
title_full Variation in antibiotic treatment for diabetic patients with serious foot infections: A retrospective observational study
title_fullStr Variation in antibiotic treatment for diabetic patients with serious foot infections: A retrospective observational study
title_full_unstemmed Variation in antibiotic treatment for diabetic patients with serious foot infections: A retrospective observational study
title_short Variation in antibiotic treatment for diabetic patients with serious foot infections: A retrospective observational study
title_sort variation in antibiotic treatment for diabetic patients with serious foot infections: a retrospective observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914722/
https://www.ncbi.nlm.nih.gov/pubmed/20604922
http://dx.doi.org/10.1186/1472-6963-10-193
work_keys_str_mv AT finckebenjaming variationinantibiotictreatmentfordiabeticpatientswithseriousfootinfectionsaretrospectiveobservationalstudy
AT millerdonaldr variationinantibiotictreatmentfordiabeticpatientswithseriousfootinfectionsaretrospectiveobservationalstudy
AT christiansencindyl variationinantibiotictreatmentfordiabeticpatientswithseriousfootinfectionsaretrospectiveobservationalstudy
AT turpinrobins variationinantibiotictreatmentfordiabeticpatientswithseriousfootinfectionsaretrospectiveobservationalstudy